136 related articles for article (PubMed ID: 38615609)
21. Regulation of lipoprotein lipase by the oxysterol receptors, LXRalpha and LXRbeta.
Zhang Y; Repa JJ; Gauthier K; Mangelsdorf DJ
J Biol Chem; 2001 Nov; 276(46):43018-24. PubMed ID: 11562371
[TBL] [Abstract][Full Text] [Related]
22. Effects of exercise training on ANGPTL3/8 and ANGPTL4/8 and their associations with cardiometabolic traits.
Hoffmann WG; Chen YQ; Schwartz CS; Barber JL; Dev PK; Reasons RJ; Miranda Maravi JS; Armstrong B; Gerszten RE; Silbernagel G; Konrad RJ; Bouchard C; Sarzynski MA
J Lipid Res; 2024 Feb; 65(2):100495. PubMed ID: 38160757
[TBL] [Abstract][Full Text] [Related]
23. Angiopoietin-like 3 inhibition of endothelial lipase is not modulated by angiopoietin-like 8.
Sylvers-Davie KL; Segura-Roman A; Salvi AM; Schache KJ; Davies BSJ
J Lipid Res; 2021; 62():100112. PubMed ID: 34461133
[TBL] [Abstract][Full Text] [Related]
24. 1,3,5,8-tetrahydroxyxanthone regulates ANGPTL3-LPL pathway to lessen the ketosis in mice.
Xiao HB; Sun ZL; Zhou N
Eur J Pharm Sci; 2012 May; 46(1-2):26-31. PubMed ID: 22342712
[TBL] [Abstract][Full Text] [Related]
25. An updated ANGPTL3-4-8 model as a mechanism of triglyceride partitioning between fat and oxidative tissues.
Zhang R; Zhang K
Prog Lipid Res; 2022 Jan; 85():101140. PubMed ID: 34793860
[TBL] [Abstract][Full Text] [Related]
26. Histone H3K9 Demethylase JMJD2B Plays a Role in LXRα-Dependent Lipogenesis.
Kim JH; Jung DY; Kim HR; Jung MH
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167594
[TBL] [Abstract][Full Text] [Related]
27. Xanthohumol Suppresses NPC1L1 Gene Expression through Downregulation of HNF-4α and Inhibits Cholesterol Uptake in Caco-2 Cells.
Thang SK; Chen PY; Gao WY; Wu MJ; Pan MH; Yen JH
J Agric Food Chem; 2019 Oct; 67(40):11119-11128. PubMed ID: 31525874
[TBL] [Abstract][Full Text] [Related]
28. Xanthohumol ameliorates atherosclerotic plaque formation, hypercholesterolemia, and hepatic steatosis in ApoE-deficient mice.
Doddapattar P; Radović B; Patankar JV; Obrowsky S; Jandl K; Nusshold C; Kolb D; Vujić N; Doshi L; Chandak PG; Goeritzer M; Ahammer H; Hoefler G; Sattler W; Kratky D
Mol Nutr Food Res; 2013 Oct; 57(10):1718-28. PubMed ID: 23650230
[TBL] [Abstract][Full Text] [Related]
29. Xanthohumol, the chalcone from beer hops (Humulus lupulus L.), is the ligand for farnesoid X receptor and ameliorates lipid and glucose metabolism in KK-A(y) mice.
Nozawa H
Biochem Biophys Res Commun; 2005 Oct; 336(3):754-61. PubMed ID: 16140264
[TBL] [Abstract][Full Text] [Related]
30. Soy protein isoflavones differentially regulate liver X receptor isoforms to modulate lipid metabolism and cholesterol transport in the liver and intestine in mice.
González-Granillo M; Steffensen KR; Granados O; Torres N; Korach-André M; Ortíz V; Aguilar-Salinas C; Jakobsson T; Díaz-Villaseñor A; Loza-Valdes A; Hernandez-Pando R; Gustafsson JÅ; Tovar AR
Diabetologia; 2012 Sep; 55(9):2469-78. PubMed ID: 22739758
[TBL] [Abstract][Full Text] [Related]
31. Beneficial effect of 3,4,5,6-tetrahydroxyxanthone on dyslipidemia in apolipoprotein E-deficient mice.
Xiao HB; Sun ZL; Lu XY; Li DZ; Xu JP; Hu YP
Can J Physiol Pharmacol; 2008 Dec; 86(12):815-26. PubMed ID: 19088802
[TBL] [Abstract][Full Text] [Related]
32. Effect of Dietary Purified Xanthohumol from Hop (Humulus lupulus L.) Pomace on Adipose Tissue Mass, Fasting Blood Glucose Level, and Lipid Metabolism in KK-Ay Mice.
Takahashi K; Osada K
J Oleo Sci; 2017 May; 66(5):531-541. PubMed ID: 28413193
[TBL] [Abstract][Full Text] [Related]
33. An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif.
Balasubramaniam D; Schroeder O; Russell AM; Fitchett JR; Austin AK; Beyer TP; Chen YQ; Day JW; Ehsani M; Heng AR; Zhen EY; Davies J; Glaesner W; Jones BE; Siegel RW; Qian YW; Konrad RJ
J Lipid Res; 2022 May; 63(5):100198. PubMed ID: 35307397
[TBL] [Abstract][Full Text] [Related]
34. Carboxyl-terminal sequences in APOA5 are important for suppressing ANGPTL3/8 activity.
Chen YQ; Yang Y; Zhen EY; Beyer TP; Li H; Wen Y; Ehsani M; Jackson N; Xie K; Jung H; Scheithauer JL; Kumari A; Birrane G; Russell AM; Balasubramaniam D; Liao Z; Siegel RW; Qian Y; Ploug M; Young SG; Konrad RJ
Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2322332121. PubMed ID: 38625948
[TBL] [Abstract][Full Text] [Related]
35. Angiopoietin-like protein 3 inhibits lipoprotein lipase activity through enhancing its cleavage by proprotein convertases.
Liu J; Afroza H; Rader DJ; Jin W
J Biol Chem; 2010 Sep; 285(36):27561-70. PubMed ID: 20581395
[TBL] [Abstract][Full Text] [Related]
36. ANGPTL3 deficiency alters the lipid profile and metabolism of cultured hepatocytes and human lipoproteins.
Ruhanen H; Haridas PAN; Minicocci I; Taskinen JH; Palmas F; di Costanzo A; D'Erasmo L; Metso J; Partanen J; Dalli J; Zhou Y; Arca M; Jauhiainen M; Käkelä R; Olkkonen VM
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Jul; 1865(7):158679. PubMed ID: 32151767
[TBL] [Abstract][Full Text] [Related]
37. RNA Interference Targeting Liver Angiopoietin-Like Protein 3 Protects from Nephrotic Syndrome in a Rat Model Via Amelioration of Pathologic Hypertriglyceridemia.
Zhao Y; Goto M; Vaziri ND; Khazaeli M; Liu H; Farahanchi N; Khanifar E; Farzaneh T; Haslett PA; Moradi H; Soundarapandian MM
J Pharmacol Exp Ther; 2021 Mar; 376(3):428-435. PubMed ID: 33443084
[TBL] [Abstract][Full Text] [Related]
38. Retinoic acid receptor-related orphan receptor α-induced activation of adenosine monophosphate-activated protein kinase results in attenuation of hepatic steatosis.
Kim EJ; Yoon YS; Hong S; Son HY; Na TY; Lee MH; Kang HJ; Park J; Cho WJ; Kim SG; Koo SH; Park HG; Lee MO
Hepatology; 2012 May; 55(5):1379-88. PubMed ID: 22183856
[TBL] [Abstract][Full Text] [Related]
39. Paeoniflorin regulates GALNT2-ANGPTL3-LPL pathway to attenuate dyslipidemia in mice.
Xiao HB; Liang L; Luo ZF; Sun ZL
Eur J Pharmacol; 2018 Oct; 836():122-128. PubMed ID: 30096295
[TBL] [Abstract][Full Text] [Related]
40. Relationship between hepatic and systemic angiopoietin-like 3, hepatic Vitamin D receptor expression and NAFLD in obesity.
Barchetta I; Cimini FA; Chiappetta C; Bertoccini L; Ceccarelli V; Capoccia D; Gaggini M; Di Cristofano C; Della Rocca C; Silecchia G; Leonetti F; Lenzi A; Gastaldelli A; Cavallo MG
Liver Int; 2020 Sep; 40(9):2139-2147. PubMed ID: 32510837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
